AstraZeneca–BMS merger talks continue…combined market cap near $400B
AZN Astrazeneca plc
$155.62 -1.49%
차트·분석 보기 → - 1Reports say merger talks between AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) are still ongoing
- 2If completed, the combined company would become the world's fourth-largest pharma with a market cap of roughly $400B, and a stock-and-cash deal is expected
- 3Commitments to U.S. investment, R&D, production, and jobs are required, and a potential full re-listing in New York has also been discussed
This 3-line summary is compiled from the report below.
Barrons.com +1 View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다